Impax Laboratories Inc. IPXL reported third-quarter 2017 adjusted earnings of ... Amneal Pharmaceuticals entered into an all-stock deal to merge and form a new publicly traded company, Amneal Pharmaceuticals Inc. The combined company …
The plaintiff alleges on behalf of purchasers of Impax Laboratories Inc (NASDAQ:IPXL) common stock during the period …
NEW YORK, Dec. 1, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Impax …
The stock has climbed 43 percent in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPXL
... INC (AXGN): Free Stock Analysis Report MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report TEVA PHARMACEUTICAL INDUSTRIES (TEVA): Free Stock Analysis Report IMPAX LABORATORIES INC (IPXL): Free …
That is because a stock needs to have both a positive Earnings ESP and a ... Story Continues The Earnings ESP for Impax Laboratories Inc. IPXL is +3.03%. The Earnings ESP for Ionis Pharmaceuticals, Inc. IONS is +38.00%. Incyte …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPXL at https://www.zacks.com/ap/IPXL Keywords: Impax Laboratories, …
Yahoo!11mon